Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,442 | -26,110 | -3,840 | -4,110 | -9,720 |
| Depreciation Amortization | 2,946 | 3,110 | 1,160 | 1,070 | 1,250 |
| Other Working Capital | 234,692 | -1,720 | -12,500 | -11,000 | 26,630 |
| Other Operating Activity | 524 | 620 | 620 | 570 | -80 |
| Operating Cash Flow | $230,720 | $-24,100 | $-14,560 | $-13,470 | $18,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -86,645 | N/A | N/A | N/A | N/A |
| PPE Investments | -8,209 | -2,390 | -420 | -1,570 | -440 |
| Net Acquisitions | N/A | 0 | -150 | 0 | 0 |
| Other Investing Activity | -40,859 | -2,690 | -700 | -2,810 | 3,840 |
| Investing Cash Flow | $-135,713 | $-5,080 | $-1,270 | $-4,380 | $3,400 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,881 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -516 | 63,730 | 26,130 | -2,760 | -910 |
| Financing Cash Flow | $3,365 | $63,730 | $26,130 | $-2,760 | $-910 |
| Exchange Rate Effect | -70 | -90 | 30 | 10 | 20 |
| Beginning Cash Position | 71,338 | 50,990 | 40,620 | 59,930 | 44,310 |
| End Cash Position | 169,640 | 85,450 | 50,950 | 39,330 | 64,910 |
| Net Cash Flow | $98,302 | $34,460 | $10,320 | $-20,600 | $20,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | 230,720 | -24,100 | -14,560 | -13,470 | 18,080 |
| Capital Expenditure | -8,209 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 222,511 | -24,100 | -14,560 | -13,470 | 18,080 |